Document is current
Any future updates will be listed below
-
Authors
Beliveau, Martin
Chang, Colin
Lewis, Lara
Letsoalo, Marothi P.
Karim, Quarraisha Abdool
Karim, Salim S. Abdool
Marzinke, Mark A.
Moss, John A.
Gengiah, Tanuja N.
Baum, Marc M.
-
Funding
Funding for this research was provided by:
EDCPT (SRIA2015-1061)
EDCTP (SRIA2015-1061)
EDCTP (SRIA2015-1061)
EDCTP (SRIA2015-1061)
EDCTP (SRIA2015-1061)
National Institute of Allergy and Infectious Diseases (R01AI162151)
National Institute of Allergy and Infectious Diseases (R01AI162151)
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 9 April 2026
First Online: 21 April 2026
Declarations
:
: Authors Martin Beliveau and Colin Chang were employed by the company Certara Drug Development Solutions. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
